Kong J, Zheng FM, Wang ZD, Zhang YY, et al. Avapritinib is effective for treatment of minimal residual disease in acute myeloid leukemia with t (8;21) and kit mutation failing to immunotherapy after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2023 Apr 6. doi: 10.1038/s41409-023-01973.
PMID: 37024571